• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[法安明、己酮可可碱、去纤苷联合治疗法廷二期下肢慢性闭塞性动脉病。个人经验]

[Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].

作者信息

Marci M, Albiani B, Ricci M, Russo F

机构信息

Divisione di Medicina Generale, USL RM/G, Ospedale A. Angelucci di Subiaco.

出版信息

Clin Ter. 1995 Mar;146(3):211-4.

PMID:7789083
Abstract

The authors provide evidence for the efficacy of the buflomedil-pentoxifylline-defibrotide combination for treatment of lower limb chronic obstructive arterial disease, Fontain stage II. Improvement of walking autonomy obtained with these agents ranged from 50 to 100% in 29 of 36 patients (relative frequency = 0.80).

摘要

作者提供了丁咯地尔 - 己酮可可碱 - 去纤苷联合用药治疗Fontain II期下肢慢性阻塞性动脉疾病疗效的证据。在36例患者中的29例（相对频率 = 0.80）中，使用这些药物后步行自主性的改善幅度为50%至100%。

相似文献

1
[Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].[法安明、己酮可可碱、去纤苷联合治疗法廷二期下肢慢性闭塞性动脉病。个人经验]
Clin Ter. 1995 Mar;146(3):211-4.
2
[Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].盐酸丁咯地尔治疗下肢慢性闭塞性动脉病的临床经验及仪器评估
Clin Ter. 1986 Jun 30;117(6):499-509.
3
[Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].盐酸丁咯地尔对下肢慢性闭塞性动脉病的血管及血液流变学影响
Minerva Cardioangiol. 1986 Nov;34(11):745-9.
4
[Clinical experience in patients with chronic peripheral obliterating arteriopathy: defibrotide versus definite molecular weight heparan sulfate (MW 7500-15000 dalton)].[慢性周围闭塞性动脉病患者的临床经验：去纤苷与特定分子量硫酸乙酰肝素（分子量7500 - 15000道尔顿）的对比]
Minerva Cardioangiol. 1996 Jan-Feb;44(1-2):33-7.
5
[Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].[用多普勒流量计评估丁咯地尔（活脑灵）给药对阻塞性慢性动脉病患者外周循环的影响]
Minerva Cardioangiol. 1985 Nov;33(11):749-56.
6
Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.去纤苷对外周动脉病患者身体机能和血液流变学状况的影响。
Clin Trials Metaanal. 1994 Apr;29(1):21-30.
7
Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.外周动脉闭塞性疾病II期患者的步行训练与药物治疗。综述。
Int Angiol. 1992 Jul-Sep;11(3):204-10.
8
Defibrotide and peripheral obliterative arterial disease: preliminary data.去纤苷与外周闭塞性动脉疾病：初步数据。
Int J Clin Pharmacol Ther Toxicol. 1989 Nov;27(11):526-9.
9
Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.丁咯地尔与己酮可可碱治疗动脉闭塞性疾病疗效的对比评估
Angiology. 1981 Oct;32(10):705-10. doi: 10.1177/000331978103201006.
10
Effects of oral and intravenous defibrotide on blood viscosity in patients with peripheral obliterative arterial disease.口服和静脉注射去纤苷对周围闭塞性动脉疾病患者血液粘度的影响。
Clin Ther. 1989 Jul-Aug;11(4):479-84.